Skip to main content
Top
Published in: European Journal of Medical Research 1/2014

Open Access 01-12-2014 | Research

Construction of microRNA and transcription factor regulatory network based on gene expression data in cardiomyopathy

Authors: Lei Wang, Jihua Hu, Haijian Xing, Min Sun, Juanli Wang, Qiang Jian, Hua Yang

Published in: European Journal of Medical Research | Issue 1/2014

Login to get access

Abstract

Background

Cardiomyopathy is a progressive myocardial disorder. Here, we attempted to reveal the possible mechanism of cardiomyopathy at the transcription level with the roles of microRNAs (miRNAs) and transcription factors (TFs) taken into account.

Method

We firstly identified differentially expressed genes (DEGs) between cardiomyopathy patients and controls with data from the gene expression omnibus (GEO) database. DEGs were associated with the canonical pathways, molecular and cellular functions, physiological system development and function in the Ingenuity Knowledge Base by using the Ingenuity Pathway Analysis (IPA) software. TFs and miRNAs that DEGs significantly enriched were identified and a double-factor regulatory network was constructed.

Results

A total of 1,680 DEGs were identified. The DEGs were enriched for various pathways, with glucocorticoid receptor signaling as the most significant. A double-factor regulatory network was constructed, including seven TFs and two miRNAs. A subnetwork under the regulation of MEF2C and SRF was also constructed to illustrate their regulatory effects on cardiac functions.

Conclusion

Our results may provide new understanding of cardiomyopathy and may facilitate further therapeutic studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006, 113: 1807–1816. 10.1161/CIRCULATIONAHA.106.174287PubMedCrossRef Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006, 113: 1807–1816. 10.1161/CIRCULATIONAHA.106.174287PubMedCrossRef
2.
go back to reference Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE: Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006, 296: 1867–1876. 10.1001/jama.296.15.1867PubMedCrossRef Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE: Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006, 296: 1867–1876. 10.1001/jama.296.15.1867PubMedCrossRef
3.
go back to reference Taylor MR, Carniel E, Mestroni L: Cardiomyopathy, familial dilated. Orphanet J Rxare Dis 2006, 1: 27. 10.1186/1750-1172-1-27CrossRef Taylor MR, Carniel E, Mestroni L: Cardiomyopathy, familial dilated. Orphanet J Rxare Dis 2006, 1: 27. 10.1186/1750-1172-1-27CrossRef
4.
go back to reference Ferreira LR, Frade AF, Santos RH, Teixeira PC, Baron MA, Navarro IC, Benvenuti LA, Fiorelli AI, Bocchi EA, Stolf NA, Chevillard C, Kalil J, Cunha-Neto E: MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in chronic Chagas disease cardiomyopathy. Int J Cardiol 2014, 175: 409–417. 10.1016/j.ijcard.2014.05.019PubMedCrossRef Ferreira LR, Frade AF, Santos RH, Teixeira PC, Baron MA, Navarro IC, Benvenuti LA, Fiorelli AI, Bocchi EA, Stolf NA, Chevillard C, Kalil J, Cunha-Neto E: MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in chronic Chagas disease cardiomyopathy. Int J Cardiol 2014, 175: 409–417. 10.1016/j.ijcard.2014.05.019PubMedCrossRef
5.
go back to reference Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL, Li BX, Shen YW, Tao LY, Zhao ZQ: MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Reports 2014, 10: 161–168. Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL, Li BX, Shen YW, Tao LY, Zhao ZQ: MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Reports 2014, 10: 161–168.
6.
go back to reference Hannenhalli S, Putt ME, Gilmore JM, Wang J, Parmacek MS, Epstein JA, Morrisey EE, Margulies KB, Cappola TP: Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 2006, 114: 1269–1276. 10.1161/CIRCULATIONAHA.106.632430PubMedCrossRef Hannenhalli S, Putt ME, Gilmore JM, Wang J, Parmacek MS, Epstein JA, Morrisey EE, Margulies KB, Cappola TP: Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 2006, 114: 1269–1276. 10.1161/CIRCULATIONAHA.106.632430PubMedCrossRef
7.
go back to reference Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4: 249–264. 10.1093/biostatistics/4.2.249PubMedCrossRef Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4: 249–264. 10.1093/biostatistics/4.2.249PubMedCrossRef
8.
go back to reference Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995, 57: 289–300. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995, 57: 289–300.
9.
go back to reference Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27: 91–105. 10.1016/j.molcel.2007.06.017PubMedPubMedCentralCrossRef Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27: 91–105. 10.1016/j.molcel.2007.06.017PubMedPubMedCentralCrossRef
11.
go back to reference Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E: The role of site accessibility in microRNA target recognition. Nat Genet 2007, 39: 1278–1284. 10.1038/ng2135PubMedCrossRef Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E: The role of site accessibility in microRNA target recognition. Nat Genet 2007, 39: 1278–1284. 10.1038/ng2135PubMedCrossRef
12.
go back to reference Rickard AJ, Funder JW, Morgan J, Fuller PJ, Young MJ: Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration? Endocrinology 2007, 148: 4829–4835. 10.1210/en.2007-0209PubMedCrossRef Rickard AJ, Funder JW, Morgan J, Fuller PJ, Young MJ: Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration? Endocrinology 2007, 148: 4829–4835. 10.1210/en.2007-0209PubMedCrossRef
13.
go back to reference Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H, Tamaki K, Hayashida K, Nakanishi H, Yoshikawa N, Shimizu N, Endo J, Katayama T, Murata M, Yuasa S, Kaneda R, Tomita K, Eguchi N, Urade Y, Asano K, Utsunomiya Y, Suzuki T, Taguchi R, Tanaka H, Fukuda K: Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest 2009, 119: 1477–1488. 10.1172/JCI37413PubMedPubMedCentralCrossRef Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H, Tamaki K, Hayashida K, Nakanishi H, Yoshikawa N, Shimizu N, Endo J, Katayama T, Murata M, Yuasa S, Kaneda R, Tomita K, Eguchi N, Urade Y, Asano K, Utsunomiya Y, Suzuki T, Taguchi R, Tanaka H, Fukuda K: Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest 2009, 119: 1477–1488. 10.1172/JCI37413PubMedPubMedCentralCrossRef
14.
go back to reference Alonso-Montes C, Naves-Diaz M, Fernandez-Martin JL, Rodriguez-Reguero J, Moris C, Coto E, Cannata-Andia JB, Rodriguez I: New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy. Mol Biol Rep 2012, 39: 8777–8785. 10.1007/s11033-012-1740-7PubMedCrossRef Alonso-Montes C, Naves-Diaz M, Fernandez-Martin JL, Rodriguez-Reguero J, Moris C, Coto E, Cannata-Andia JB, Rodriguez I: New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy. Mol Biol Rep 2012, 39: 8777–8785. 10.1007/s11033-012-1740-7PubMedCrossRef
15.
go back to reference Xu J, Gong NL, Bodi I, Aronow BJ, Backx PH, Molkentin JD: Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J Biol Chem 2006, 281: 9152–9162. 10.1074/jbc.M510217200PubMedCrossRef Xu J, Gong NL, Bodi I, Aronow BJ, Backx PH, Molkentin JD: Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J Biol Chem 2006, 281: 9152–9162. 10.1074/jbc.M510217200PubMedCrossRef
16.
go back to reference Dasgupta T, Stillwagon SJ, Ladd AN: Gene expression analyses implicate an alternative splicing program in regulating contractile gene expression and serum response factor activity in mice. PLoS One 2013, 8: e56590. 10.1371/journal.pone.0056590PubMedPubMedCentralCrossRef Dasgupta T, Stillwagon SJ, Ladd AN: Gene expression analyses implicate an alternative splicing program in regulating contractile gene expression and serum response factor activity in mice. PLoS One 2013, 8: e56590. 10.1371/journal.pone.0056590PubMedPubMedCentralCrossRef
17.
go back to reference Tritsch E, Mallat Y, Lefebvre F, Diguet N, Escoubet B, Blanc J, De Windt LJ, Catalucci D, Vandecasteele G, Li Z, Mericskay M: An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. Cardiovasc Res 2013, 98: 372–380. 10.1093/cvr/cvt042PubMedCrossRef Tritsch E, Mallat Y, Lefebvre F, Diguet N, Escoubet B, Blanc J, De Windt LJ, Catalucci D, Vandecasteele G, Li Z, Mericskay M: An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. Cardiovasc Res 2013, 98: 372–380. 10.1093/cvr/cvt042PubMedCrossRef
18.
go back to reference Jiang J, Wakimoto H, Seidman JG, Seidman CE: Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy. Science 2013, 342: 111–114. 10.1126/science.1236921PubMedPubMedCentralCrossRef Jiang J, Wakimoto H, Seidman JG, Seidman CE: Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy. Science 2013, 342: 111–114. 10.1126/science.1236921PubMedPubMedCentralCrossRef
19.
go back to reference Lu D, Zhang L, Bao D, Lu Y, Zhang X, Liu N, Ge W, Gao X, Li H, Zhang L: Calponin1 inhibits dilated cardiomyopathy development in mice through the epsilonPKC pathway. Int J Cardiol 2014, 173: 146–153. 10.1016/j.ijcard.2014.02.032PubMedCrossRef Lu D, Zhang L, Bao D, Lu Y, Zhang X, Liu N, Ge W, Gao X, Li H, Zhang L: Calponin1 inhibits dilated cardiomyopathy development in mice through the epsilonPKC pathway. Int J Cardiol 2014, 173: 146–153. 10.1016/j.ijcard.2014.02.032PubMedCrossRef
20.
go back to reference Asanuma H, Kitakaze M: Carperitide and adiponectin - how are they connected each other to benefit acute decompensated heart failure? Circ J 2009, 73: 2206–2207. http://www.ncbi.nlm.nih.gov/pubmed/19940369 10.1253/circj.CJ-09-0785PubMedCrossRef Asanuma H, Kitakaze M: Carperitide and adiponectin - how are they connected each other to benefit acute decompensated heart failure? Circ J 2009, 73: 2206–2207. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​19940369 10.1253/circj.CJ-09-0785PubMedCrossRef
21.
go back to reference Tarazon E, Rosello-Lleti E, Rivera M, Ortega A, Molina-Navarro MM, Trivino JC, Lago F, Gonzalez-Juanatey JR, Orosa P, Montero JA, Salvador A, Portolés M: RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy. PLoS One 2014, 9: e90157. 10.1371/journal.pone.0090157PubMedPubMedCentralCrossRef Tarazon E, Rosello-Lleti E, Rivera M, Ortega A, Molina-Navarro MM, Trivino JC, Lago F, Gonzalez-Juanatey JR, Orosa P, Montero JA, Salvador A, Portolés M: RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy. PLoS One 2014, 9: e90157. 10.1371/journal.pone.0090157PubMedPubMedCentralCrossRef
Metadata
Title
Construction of microRNA and transcription factor regulatory network based on gene expression data in cardiomyopathy
Authors
Lei Wang
Jihua Hu
Haijian Xing
Min Sun
Juanli Wang
Qiang Jian
Hua Yang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2014
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-014-0057-5

Other articles of this Issue 1/2014

European Journal of Medical Research 1/2014 Go to the issue